scholarly journals Prognostic value of CAIX expression in oral squamous cell carcinoma: a systematic review and meta-analysis

2020 ◽  
Vol 35 (1) ◽  
pp. 1258-1266 ◽  
Author(s):  
Alejandro I. Lorenzo-Pouso ◽  
Mercedes Gallas-Torreira ◽  
Mario Pérez-Sayáns ◽  
Cintia M. Chamorro-Petronacci ◽  
Oscar Alvarez-Calderon ◽  
...  
Biomedicines ◽  
2021 ◽  
Vol 9 (5) ◽  
pp. 486
Author(s):  
Juan P. Rodrigo ◽  
Mario Sánchez-Canteli ◽  
Fernando López ◽  
Gregory T. Wolf ◽  
Juan C. Hernández-Prera ◽  
...  

The presence of tumor-infiltrating lymphocytes (TIL) in the tumor microenvironment has been demonstrated to be of prognostic value in various cancers. In this systematic review and meta-analysis, we investigated the prognostic value of TIL in laryngeal squamous cell carcinoma (LSCC). We performed a systematic search in PubMed for publications that investigated the prognostic value of TIL in LSCC. A meta-analysis was performed including all studies assessing the association between TIL counts in hematoxylin-eosin (HE)-stained sections, for CD8+ and/or CD3+/CD4+ TIL and overall survival (OS) or disease-free survival (DFS). The pooled meta-analysis showed a favorable prognostic role for stromal TIL in HE sections for OS (HR 0.57, 95% CI 0.36–0.91, p = 0.02), and for DFS (HR 0.56, 95% CI 0.34–0.94, p = 0.03). High CD8+ TIL were associated with a prolonged OS (HR 0.62, 95% CI 0.4–0.97, p = 0.04) and DFS (HR 0.73, 95% CI 0.34–0.94, p = 0.002). High CD3+/CD4+ TIL demonstrated improved OS (HR 0.32, 95% CI 0.16–0.9, p = 0.03) and DFS (HR 0.23, 95% CI 0.10–0.53, p = 0.0005). This meta-analysis confirmed the favorable prognostic significance of TIL in LSCC. High stromal TIL evaluated in HE sections and intra-tumoral and stromal CD3+, CD4+ and/or CD8+ TIL might predict a better clinical outcome.


2020 ◽  
Vol 9 (4) ◽  
pp. 3092-3100 ◽  
Author(s):  
Shivaranjhany Sivakumar ◽  
Archana A. Gupta ◽  
Nik Mohd Mazuan Nik Mohd Rosdy ◽  
Annapurny Venkiteswaran ◽  
A. Thirumal Raj ◽  
...  

2021 ◽  
Vol 11 (1) ◽  
pp. 33-39
Author(s):  
Nilookumari Choudhary ◽  
Gargi S. Sarode ◽  
Monal Yuwanati ◽  
Nikunj Maniyar ◽  
Sachin C. Sarode ◽  
...  

2019 ◽  
Vol 25 (2) ◽  
pp. 447-453 ◽  
Author(s):  
K. Hema Shree ◽  
Pratibha Ramani ◽  
Herald Sherlin ◽  
Gheena Sukumaran ◽  
Gifrrina Jeyaraj ◽  
...  

2020 ◽  
Vol 21 (19) ◽  
pp. 7255
Author(s):  
Shrabon Hasnat ◽  
Roosa Hujanen ◽  
Bright I. Nwaru ◽  
Tuula Salo ◽  
Abdelhakim Salem

Head and neck squamous cell carcinoma (HNSCC) is a group of tumours which exhibit low 5 year survival rates. Thus, there is an urgent need to identify biomarkers that may improve the clinical utility of patients with HNSCC. Emerging studies support a role of toll-like receptors (TLRs) in carcinogenesis. Therefore, this systematic review and meta-analysis was performed to assess the prognostic value of TLR immunoexpression in HNSCC patients. We compiled the results of thirteen studies comprising 1825 patients, of which six studies were deemed qualified for quantitative synthesis. The higher immunoexpression of TLR-1 to 5 and 9 was associated with a worsening of the clinical parameters of patients with HNSCC. Furthermore, induced levels of TLR-3, 4, 5, 7 and 9 were found to predict the patients’ survival time. The meta-analysis revealed that TLR-7 overexpression is associated with a decreased mortality risk in HNSCC patients (HR 0.51; 95%CI 0.13–0.89; I2 34.6%), while a higher expression of TLR-5 predicted shorter, but non-significant, survival outcome. In conclusion, this review suggests that TLRs may represent some prognostic value for patients with HNSCC. However, due to small sample sizes and other inherent methodological limitations, more well designed studies across different populations are still needed before TLRs can be recommended as a reliable clinical risk-stratification tool.


2018 ◽  
Vol 129 (8) ◽  
pp. E284-E298 ◽  
Author(s):  
Conner Massey ◽  
Anbuselvan Dharmarajan ◽  
Raveendhara R. Bannuru ◽  
Elie Rebeiz

Oral Oncology ◽  
2020 ◽  
Vol 106 ◽  
pp. 104722 ◽  
Author(s):  
Daniel Lenouvel ◽  
Miguel Ángel González-Moles ◽  
Isabel Ruiz-Ávila ◽  
Lucia Gonzalez-Ruiz ◽  
Isabel Gonzalez-Ruiz ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document